These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Changing concepts in the systemic treatment of locally advanced or metastatic soft tissue sarcomas. Verweij J; Pinedo HM Cancer Treat Res; 1993; 67():107-16. PubMed ID: 8102868 [No Abstract] [Full Text] [Related]
6. Role of adjuvant chemotherapy in the management of patients with soft tissue sarcomas. Edmonson JH Cancer Treat Rep; 1984 Sep; 68(9):1063-6. PubMed ID: 6383603 [No Abstract] [Full Text] [Related]
7. The reason for confining the use of adjuvant chemotherapy in soft tissue sarcoma to the investigational setting. Verweij J; Seynaeve C Semin Radiat Oncol; 1999 Oct; 9(4):352-9. PubMed ID: 10516382 [TBL] [Abstract][Full Text] [Related]
8. Chemotherapy in advanced soft tissue sarcomas. Verweij J; van Groeningen CJ; Pinedo HM Cancer Treat Res; 1989; 44():75-92. PubMed ID: 2577163 [No Abstract] [Full Text] [Related]
10. [Results of chemotherapy of soft tissue sarcoma in adults]. Santoro A; Viviani S Radiol Med; 1984 Nov; 70(11):893-5. PubMed ID: 6399763 [No Abstract] [Full Text] [Related]
11. The present state of the art in chemotherapy for soft tissue sarcomas in adults: the EORTC point of view. Verweij J; Mouridsen HT; Nielssen OS; Woll PJ; Somers R; van Oosterom AT; Van Glabbeke M; Tursz T Crit Rev Oncol Hematol; 1995 Oct; 20(3):193-201. PubMed ID: 8748009 [No Abstract] [Full Text] [Related]
12. Systemic treatment of advanced or metastatic soft tissue sarcomas. Verweij J; Pinedo HM Cancer Treat Res; 1991; 56():75-91. PubMed ID: 1681881 [No Abstract] [Full Text] [Related]
14. Chemotherapy in the multidisciplinary approach to soft tissue sarcomas. EORTC Soft Tissue and Bone Sarcoma Group studies in perspective. Verweij J; van Oosterom AT; Somers R; Santoro A; Rouëssé J; Keizer J; Tursz T; Woll P; Steward W; Buesa J Ann Oncol; 1992 Apr; 3 Suppl 2():S75-80. PubMed ID: 1622874 [No Abstract] [Full Text] [Related]
15. Results of single-agent and combination chemotherapy for advanced soft tissue sarcomas. Implications for decision making in the clinic. Demetri GD; Elias AD Hematol Oncol Clin North Am; 1995 Aug; 9(4):765-85. PubMed ID: 7490240 [TBL] [Abstract][Full Text] [Related]
16. The Value of Neoadjuvant Chemotherapy in Localized High-Risk Soft-Tissue Sarcoma of the Extremities and Trunk. Gronchi A; Jones RL JAMA Oncol; 2018 Sep; 4(9):1167-1168. PubMed ID: 29879269 [No Abstract] [Full Text] [Related]
17. Has "MAID" made it in the management of high-risk soft-tissue sarcoma? O'Sullivan B; Bell RS Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):915-6. PubMed ID: 12829123 [No Abstract] [Full Text] [Related]
18. Current perspectives in the management of soft-tissue sarcoma. The role of chemotherapy in multimodality therapy. Bramwell VH Can J Surg; 1988 Nov; 31(6):390-6. PubMed ID: 3052763 [TBL] [Abstract][Full Text] [Related]
19. [Preoperative chemotherapy in treatment of soft tissue sarcoma]. Rosen G; Eilber F; Eckardt J; Holmes C; Forscher CA; Lowenbraun S; Selch M; Fu YS Chirurg; 1993 Jun; 64(6):443-8. PubMed ID: 8359055 [No Abstract] [Full Text] [Related]
20. Effectiveness of chemotherapy in non-rhabdomyosarcoma soft tissue sarcomas. Ferrari A; Collini P Pediatr Blood Cancer; 2005 Aug; 45(2):226-7; author reply 228. PubMed ID: 15782404 [No Abstract] [Full Text] [Related] [Next] [New Search]